AkzoNobel's Q3 2013 revenue was down 5% due to adverse currency effects and divestments. Operating income increased due to lower restructuring costs and higher volumes. Net income attributable to shareholders was €155 million. The performance improvement program is on track to deliver €500 million in EBITDA benefits by the end of 2013. However, continued weak markets and higher restructuring charges mean full-year operating income is unlikely to exceed €908 million.
Presentation by Meriel Norris for the ESRC Seminar Series on Ageing and Physical Activity - "Physical activity among hard to reach groups: Issues for research, policy and practice"
http://seminars.ecehh.org
AkzoNobel's Q3 2013 revenue was down 5% due to adverse currency effects and divestments. Operating income increased due to lower restructuring costs and higher volumes. Net income attributable to shareholders was €155 million. The performance improvement program is on track to deliver €500 million in EBITDA benefits by the end of 2013. However, continued weak markets and higher restructuring charges mean full-year operating income is unlikely to exceed €908 million.
Presentation by Meriel Norris for the ESRC Seminar Series on Ageing and Physical Activity - "Physical activity among hard to reach groups: Issues for research, policy and practice"
http://seminars.ecehh.org
